Seeking Alpha

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that...

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that Roche's (RHHBY.PK +2.5%) Lucentis market share is declining, and the number of patients switching to Eylea from other treatments is accelerating. The firm maintains an Outperform rating on the stock.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs